一种自然存在的SHLP2变体是帕金森病的保护因素
Su-Jeong Kim1, Brendan Miller1, Nicolas G Hartel2
1The Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA, USA.
Molecular psychiatry
|January 3, 2024
概括
与较低帕金森病风险相关的特定线粒体DNA变体 (mtSNP) 创造了一个更稳定的,SHLP2. 这种稳定的可以防止线粒体功能障碍和帕金森病相关毒素.
科学领域:
- 遗传学 遗传学 是一个
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体DNA单核酸多态 (mtSNPs) 与降低帕金森病 (PD) 风险有关.
- 这种关联背后的功能机制尚不清楚.
研究的目的:
- 研究一种与PD相关的mtSNP影响线粒体衍生 (MDP) 小人胺类2 (SHLP2) 的功能作用.
- 探索SHLP2变体对PD相关线粒体功能障碍的保护机制.
主要方法:
- 在SHLP2编码区域内识别m.2158 T>C mtSNP.
- 在神经元细胞中使用向质谱学分析SHLP2变体 (WT和K4R).
- 对SHLP2与线粒体复合体结合的评估 1.
- 在小鼠模型中评估SHLP2对线粒体功能障碍和对PD诱导毒素的保护.
主要成果:
- m.2158 T>C mtSNP导致一种具有更高稳定性的替代SHLP2形式 (K4R).
- 无论是WT还是K4R,SHLP2都与线粒体复合体1结合.
- 在体内,SHLP2变体表现出对线粒体功能障碍和PD诱导毒素的增强保护.
结论:
- m.2158 T>C mtSNP 影响了 SHLP2 的功能和稳定性.
- SHLP2对与帕金森病相关的线粒体功能障碍起着保护作用.
- 这项研究提供了关于mtSNPs如何保护PD的机制性见解.
更多相关视频
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
15.1K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
相关概念视频
Parkinson's Disease: Overview
553
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
553
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
273
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
273
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
